Showing results (651-660 of 679) with videos related to

Sort By:
Pageof 68
The American Journal of Tropical Medicine and Hygiene|January 17, 2002
The appearance of a second genotype of Japanese encephalitis virus in the Australasian regionA T Pyke, D T Williams, D J Nisbet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2019
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancerJ F Liu, W T Barry, M Birrer, et al.
Diabetologia|January 16, 2010
Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian menE S Tai, M L S Tan, R D Stevens, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 20, 2015
Pandemic influenza virus, pH1N1, induces asthmatic symptoms via activation of innate lymphoid cellsD H Shim, Y A Park, M J Kim, et al.
Scientific Reports|December 3, 2015
Crossover from a heavy fermion to intermediate valence state in noncentrosymmetric Yb2Ni12(P,As)7W B Jiang, L Yang, C Y Guo, et al.
Oncogene|December 5, 2012
Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibodyJ M Lee, B Kim, S B Lee, et al.
European Journal of Neurology|October 31, 2017
Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairmentJ Lee, S W Seo, J-J Yang, et al.
Emerging Infectious Diseases|September 30, 2010
Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, SingaporeMark I C Chen, Vernon J M Lee, Ian Barr, et al.
Oncogene|March 26, 2014
Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapyB Kim, S Wang, J M Lee, et al.
European Radiology|July 22, 2015
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agentsE Neri, M A Bali, A Ba-Ssalamah, et al.
Pageof 68